缅北强奸

For a long time, the main obstacle to creating an AIDS vaccine has been the high genetic variability of the HIV virus. Dr. Jean-Pierre Routy and his team from the Research Institute of the 缅北强奸 Health Centre (MUHC), in collaboration with Dr. Rafick S茅kaly from the Universit茅 de Montr茅al, with ARGOS Therapeutics (North Carolina, US) an industrial partner, have overcome this difficulty by designing a personalized immunotherapy for HIV-infected patients.